Shares of PhenixFIN Co. (NYSE:PFX – Get Rating) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $35.36 and traded as low as $34.94. PhenixFIN shares last traded at $34.94, with a volume of 312 shares changing hands.
PhenixFIN Price Performance
The company has a market capitalization of $73.02 million, a PE ratio of -30.92 and a beta of 1.18. The firm has a fifty day moving average of $36.06 and a two-hundred day moving average of $35.36. The company has a current ratio of 3.83, a quick ratio of 3.83 and a debt-to-equity ratio of 0.60.
Insider Activity at PhenixFIN
In related news, Director Howard Amster bought 1,850 shares of the company’s stock in a transaction that occurred on Tuesday, February 28th. The stock was bought at an average cost of $38.60 per share, for a total transaction of $71,410.00. Following the acquisition, the director now directly owns 232,888 shares of the company’s stock, valued at approximately $8,989,476.80. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 20.80% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On PhenixFIN
PhenixFIN Company Profile
Medley Capital Corporation is a non-diversified closed-end management investment company. The Company’s investment objective is to generate current income and capital appreciation by lending directly to privately-held middle market companies, primarily through directly originated transactions to help these companies expand their business, refinance and make acquisitions.
Featured Articles
- Get a free copy of the StockNews.com research report on PhenixFIN (PFX)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for PhenixFIN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhenixFIN and related companies with MarketBeat.com's FREE daily email newsletter.